Changes in Siegfried Management
The Board of Directors of Siegfried Holding AG appointed Dr. René Imwinkelried, Ph.D., the company’s new Head Research & Development and member of the Executive Committee. He is currently Head of Technical Development Small Molecules at Roche in Basel. René Imwinkelried will start in his new function on September 1st, 2012.
Following a Ph.D. degree in organic chemistry from the Swiss Federal Institute of Technology (ETH) Zurich, René Imwinkelried completed a postdoctoral fellowship at both Colorado State University and Harvard University. Prior to his current position at Roche, he executed various R&D functions at Lonza between 1991 and 2004 and held the position of Head of Global Chemical and Physical Sciences at the US pharmaceutical company Schering-Plough from 2004 to 2010.
He succeeds Wolfgang Wienand, Ph.D., who held this position since August 2010 and will now focus on further developing Strategy and Mergers & Acquisitions in the Executive Committee and on his responsibility for Legal and IP Management. Wolfgang Wienand will continue to execute both functions until René Imwinkelried joins Siegfried.
Other news from the department people
